Retinal vascular caliber associated with cardiac and renal target organ damage in never-treated hypertensive patients

Vincent Daien1,2,3, Loic Granados1,2, Ryo Kawasaki4

  • 1Department of Opthalmology, Hôpital Gui de Chauliac, Montpellier, France.

Microcirculation (New York, N.Y. : 1994)
|December 18, 2016
PubMed

Insights

Reduced retinal vascular caliber, measured as arteriolar (CRAE) and venular (CRVE) equivalents, is linked to early cardiac and kidney damage in hypertension patients. This finding highlights the importance of retinal imaging for assessing cardiovascular and renal risk.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Nephrology

Background:

  • Hypertension (HT) is a major risk factor for cardiovascular and renal diseases.
  • Early detection of target organ damage is crucial for managing HT.
  • Retinal vascular caliber may serve as a non-invasive indicator of systemic vascular health.

Purpose of the Study:

  • To investigate the association between retinal vascular caliber and preclinical target organ damage in never-treated hypertension patients.
  • To determine if retinal vascular caliber correlates with cardiac, renal, and vascular stiffness parameters.

Main Methods:

  • Retinal vascular calibers (CRAE and CRVE) were measured from fundus photographs in 88 never-treated HT subjects.
  • Cardiac assessment included left ventricular hypertrophy.
  • Renal function was evaluated by urinary albumin excretion and estimated glomerular filtration rate (eGFR).
  • Vascular stiffness was assessed using carotid-to-femoral pulse wave velocity and carotid augmentation index.

Main Results:

  • Reduced mean CRAE and CRVE were significantly associated with left ventricular hypertrophy.
  • Both CRAE and CRVE showed a negative correlation with urinary albumin excretion.
  • No significant correlation was found between retinal vascular caliber and eGFR, pulse wave velocity, or carotid augmentation index.

Conclusions:

  • In never-treated HT patients, narrower retinal arterioles and venules are associated with cardiac (left ventricular hypertrophy) and renal (albuminuria) preclinical damage.
  • Retinal vascular caliber does not appear to be correlated with eGFR or vascular stiffness in this cohort.
  • Retinal imaging may offer a valuable tool for identifying hypertension patients at risk for target organ damage.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
690
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K